% | $
Quotes you view appear here for quick access.

Avanir Pharmaceuticals, Inc. Message Board

  • theefalcon theefalcon Jan 17, 2013 10:00 AM Flag

    2013 AAN Annual Meeting

    2013 AAN Annual Meeting
    March 16–March 23
    San Diego Convention Centre

    Exhibits and Sponsors
    Avanir Pharmaceuticals, Inc. Booth 1701 Just Left of the main front entrance, nicely placed.
    Avanir Pharmaceuticals, Inc. Booth 1704 Just down from the above.

    AAN Advertising
    The largest international meeting of neurologists and neuroscience professionals
    The Annual Meeting is one of the largest neurology meetings worldwide
    More than 12,000 attendees at last year's meeting in New Orleans
    One of the world's leaders in providing neurology related CME programming for Maintenance of Certification
    Many marketing and sponsorship opportunities to create and build awareness.

    Not sure if the above has been posted before.

    On the AAN Web site you can get to the floor plan to see all the Exhibitors positions.

    Have a pleasant day all.

    Sr Falconi

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Thank you Falconi!...excellent insight/info as always. You inspired me to look for relevant abstracts at the meeting. So far I have found the following (more detail on the AAN website):

      1 [P04.029] Dextromethorphan/Quinidine Attenuates Compulsive Shopping Behaviors and Pseudobulbar Affect in Individuals with Traumatic Brain Injury
      Authors: Christine M. Zakrzewski, Flanders, NJ, Phillip A. DeFina, Flanders, NJ, Jonathan Fellus, Flanders, NJ
      Date/Time: Wednesday, March 20, 2013 - 7:30 AM
      Session Info: Session P04: Neural Repair: Traumatic Brain Injury (7:30 AM-12:00 PM)

      2 [P05.164] Dextromethorphan Protects Cells in the Oligodendroglial Lineage and Stimulates Glial Proliferation
      Authors: Robert Lisak, Detroit, MI, Liljana Nedelkoska, Detroit, MI, Beverly Bealmear, Detroit, MI, Joyce Benjamins, Detroit, MI
      Date/Time: Wednesday, March 20, 2013 - 2:00 PM
      Session Info: Session P05: Multiple Sclerosis: Treatment Mechanism of Action (2:00 PM-7:00 PM)

      2 [P03.215] PRISM Registry: A Novel Tool To Estimate the Prevalence of Pseudobulbar Affect Symptoms
      Authors: Benjamin Brooks, Charlotte, NC, David Crumpacker, Plano, TX, Jonathan Fellus, Secaucus, NJ, Daniel Kantor, Ponte Vedra Beach, FL, Randall Kaye, Aliso Viejo, CA
      Date/Time: Tuesday, March 19, 2013 - 2:00 PM
      Session Info: Session P03: Multiple Sclerosis: Quality of Life and MS Symptoms (2:00 PM-6:30 PM)

      3 [P05.125] Indentifying the Correlates of Pseudobulbar Affect in Patients with Parkinsonsonian Disorders and ALS
      Authors: Neepa Patel, Houston, TX, Michele York, Houston, TX, Cecile Phan, Houston, TX, Joohi Jimenez Shahed, Houston, TX
      Date/Time: Wednesday, March 20, 2013 - 2:00 PM
      Session Info: Session P05: Behavioral Neurology: Neuropsychiatry, Emotions, and Behavior (2:00 PM-7:00 PM)

      4 [P07.073] Pseudobulbar Affect (PBA) in an Incident ALS Cohort: Results from the Apulia Registry
      Authors: Rosanna Tortelli, Bari, Italy, Marianna Tursi, Bari, Italy, Annalisa Iurillo, Bari, Italy, Maria Barulli, Bari, Italy, Rosa Capozzo, Bari, Italy, Rosa Cortese, Bari, Italy, Eustachio D'Errico, Bari, Italy, Isabella Simone, Bari, Italy, Giancarlo Logroscino, Bari, Italy
      Date/Time: Thursday, March 21, 2013 - 2:00 PM
      Session Info: Session P07: Anterior Horn: Clinical Studies (2:00 PM-7:00 PM)

      • 1 Reply to onlyfactsplease
      • Hello Onlyfacts – Likewise and thank you.

        I was looking at the web site earlier for a brief while thinking that some additional information may be present, as I recall some was posted in respect of past events, probably by your good self.

        WOW thank you for the extracts you have highlighted to date, brilliant.

        Sr Falconi

        Sentiment: Hold

    • greatdayforinvestments greatdayforinvestments Jan 17, 2013 10:38 AM Flag

      Thanks Sr Falconi!

      Sentiment: Strong Buy